Tiempo libre de SIDA y supervivencia de una cohorte de usuarios de drogas por vía parenteral seroconvertores frente al VIH

Muñoz, 1997, The incubation period of AIDS, AIDS, 11, S69 Alcabes, 1993, Incubation period of human immunodeficiency virus, Epidemiol Rev, 15, 303, 10.1093/oxfordjournals.epirev.a036122 Kaslow, 1987, The Multicenter AIDS Cohort Study: rationale, organization and selected characteristics of the participants, Am J Epidemiol, 126, 310, 10.1093/aje/126.2.310 Van Griensven, 1987, Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands, Am J Epidemiol, 125, 1048, 10.1093/oxfordjournals.aje.a114620 Veugelers, 1994, Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study, Am J Epidemiol, 140, 747, 10.1093/oxfordjournals.aje.a117322 Rutherford, 1990, Course of HIV-1 infection in a cohort of homosexual and bisexual men in hepatitis B vaccine trials, 1978–1988, BMJ, 301, 1183, 10.1136/bmj.301.6762.1183 Hessol, 1994, Progression of human immunodeficiency virus type 1(HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City and San Francisco, 1978–1991, Am J Epidemiol, 139, 1077, 10.1093/oxfordjournals.aje.a116951 Hendriks, 1993, The treatment-free incubation period of AIDS in a cohort of homosexual men, AIDS, 7, 231, 10.1097/00002030-199302000-00012 Taylor, 1990, Estimating the distribution of times form HIV seroconversion to AIDS using multiple imputation, Stat Med, 9, 505, 10.1002/sim.4780090504 Bacheti, 1989, Incubation period of AIDS in San Francisco, Nature, 338, 251, 10.1038/338251a0 Chevret, 1996, A new approach to estimating AIDS incubation times: results in homosexual infected men, J Epidemiol Comm Health, 46, 582, 10.1136/jech.46.6.582 Muñoz, 1996, Models for the Incubation of AIDS and Variations According to Age and Period, Stat Med, 15, 2459, 10.1002/(SICI)1097-0258(19961130)15:22<2459::AID-SIM464>3.0.CO;2-Q Brettle, 1996, Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983–1985, AIDS, 10, 419, 10.1097/00002030-199604000-00011 1992, Disease progression and early predictors of AIDS in HIV seroconverted injecting drug users, AIDS, 6, 421, 10.1097/00002030-199204000-00010 Rosenberg, 1994, Effect of age at seroconversion on the natural AIDS incubation distribution. Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters, AIDS, 8, 803, 10.1097/00002030-199406000-00013 Carre, 1994, Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIVinfected patients, AIDS, 8, 797, 10.1097/00002030-199406000-00012 Pezzoti, 1996, Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with know dates or seroconversion, BMJ, 313, 583, 10.1136/bmj.313.7057.583 Prins, 1997, Comparison of progression and nonprogression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion, AIDS, 11, 621, 10.1097/00002030-199705000-00010 Van Haastrecht, 1996, Predictors of mortality in Amsterdam cohort of Human Immunodeficiency Virus (HIV)-positive and HIV-negative drug users, Am J Epidemiol, 143, 380, 10.1093/oxfordjournals.aje.a008752 Hernández-Aguado, 1993, Prevalencia de la infección por el virus de la inmunodeficiencia humana en consumidores de drogas por vía parenteral en la Comunidad Valenciana (1987–1991), Med Clin (Barc), 100, 164 Aviñó, 1994, Incidencia de la infección por el virus de la inmunodeficiencia humana tipo 1 (VIH-1) en usuarios de drogas por vía parenteral, Med Clin (Barc), 102, 369 1987, Revision of the CDC surveillance case definiton for acquired immunodeficiency syndrome, MMWR, 6, 1S 1992, Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR, RR-17, 1 Van Benthem, 1997, Modelling the AIDS incubation time: evaluation of three right censoring strategies [letter], AIDS, 11, 834 Statistics and Epidemiology Research Corporation: EGRET. Reference Manual, Seatle, SERC; 1992: Pérez-Hoyos, 1997 1995 Veugelers, 1993, Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual men, AIDS, 7, 1325, 10.1097/00002030-199310000-00004 Seaman, 1997, Pre-aids mortality in the Edinburgh city hospital HIV cohort, Stat Med, 16, 2459, 10.1002/(SICI)1097-0258(19971115)16:21<2459::AID-SIM677>3.0.CO;2-8 Alcabes, 1994, Maturity of Human Inmunodeficiency Virus Infection and Incubation Period of Acquired Immunodeficiency Syndrome in Injecting Drug Users, Ann Epidemiol, 17, 10.1016/1047-2797(94)90038-8 Gauvreau, 1994, The effect of covariates on the induction time of aids using improved imputation of exact seroconversion times, Stat Med, 13, 2021, 10.1002/sim.4780131912 Law, 1992, Effects of mid-point imputation on the analysis of doubly censored data, Stat Med, 11, 1569, 10.1002/sim.4780111204 Ronald, 1994, Continued drug use and other cofactors for progression to AIDS among injecting drug users, AIDS, 8, 339, 10.1097/00002030-199403000-00007 Spijkerman, 1996, Differences in Progression to AIDS between Injection Drug Users and Homosexual Men in Documented Dates of Seroconversion, Epidemiology, 7, 571, 10.1097/00001648-199611000-00002 Van Haastrecht, 1994, High mortality among HIVinfected injecting drug users wihtout Aids-diagnosis: implications for HIV-infection epidemic modellers?, AIDS, 8, 363, 10.1097/00002030-199403000-00011 Muñoz, 1992, Estimation of time since exposure for a prevalent cohort, Stat Med, 11, 939, 10.1002/sim.4780110711 Jacobson, 1998, Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy, AIDS, 12, S157 Muñoz, 1995, Use of cohort studies for evaluating AIDS therapies, 423